No abstract available
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-HIV Agents / adverse effects
-
Antiretroviral Therapy, Highly Active / adverse effects*
-
Blepharoptosis / chemically induced
-
Blepharoptosis / metabolism
-
Blepharoptosis / physiopathology
-
DNA, Mitochondrial / drug effects
-
Didanosine / adverse effects
-
Genetic Predisposition to Disease / genetics
-
HIV Infections / drug therapy*
-
Humans
-
Lipodystrophy / chemically induced
-
Lipodystrophy / metabolism
-
Lipodystrophy / physiopathology
-
Male
-
Middle Aged
-
Mitochondria / drug effects
-
Mitochondria / metabolism
-
Mitochondria / pathology
-
Mitochondrial Diseases / chemically induced*
-
Mitochondrial Diseases / genetics
-
Mitochondrial Diseases / physiopathology*
-
Muscle, Skeletal / drug effects
-
Muscle, Skeletal / pathology
-
Muscle, Skeletal / physiopathology
-
Mutation / genetics
-
Oculomotor Muscles / drug effects
-
Oculomotor Muscles / pathology
-
Oculomotor Muscles / physiopathology
-
Ophthalmoplegia / chemically induced
-
Ophthalmoplegia / metabolism
-
Ophthalmoplegia / physiopathology
-
Ophthalmoplegia, Chronic Progressive External / chemically induced*
-
Ophthalmoplegia, Chronic Progressive External / metabolism
-
Ophthalmoplegia, Chronic Progressive External / physiopathology*
-
Recovery of Function / physiology
-
Risk Factors
-
Time
Substances
-
Anti-HIV Agents
-
DNA, Mitochondrial
-
Didanosine